<p>Cardiol Therapeutics Inc.（多伦多证券交易所代码：CRDL - 获取免费报告）在周一的午盘交易中股价下跌了 17.2%。该公司的股价最低曾达到 C$1.24，最后交易价为 C$1.25。午盘交易中大约有 480,129 股成交，较平均每日成交量 108,711 股增加了 342%。该股票此前收盘价为 C$1.51。</p>
<p>获取 <strong>Cardiol Therapeutics</strong> 的提醒：</p>
<h2>Cardiol Therapeutics 价格表现</h2>
<p>该公司的市值为 1.29 亿加元，市盈率为-3.15，贝塔值为 1.31。公司的债务与股本比率为 1.59，流动比率为 2.49，速动比率为 6.84。该公司的 50 日移动平均线为 C$1.50，200 日移动平均线为 C$1.65。</p>
<p>Cardiol Therapeutics（多伦多证券交易所代码：CRDL - 获取免费报告）最近在 11 月 13 日（星期四）发布了季度财报。该公司报告本季度每股收益（EPS）为 C($0.12)。分析师预测 Cardiol Therapeutics Inc.在当前财政年度将发布-0.49 的每股收益。</p>
<h2>关于 Cardiol Therapeutics</h2>
<p>（获取免费报告）</p>
<p>Cardiol Therapeutics Inc.（纳斯达克代码：CRDL，TSX 代码：CRDL）是一家临床阶段的生命科学公司，专注于心脏病的抗炎和抗纤维化疗法的研究与临床开发。该公司的主要药物候选者 CardiolRxTM（大麻二酚）口服溶液，经过药品制造，并正在进行临床开发，用于治疗心脏病。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比 Cardiol Therapeutics 更好</li>
<li>如何投资小盘股</li>
<li>与三只顶级零售 ETF 一起购物</li>
<li>异常成交量的股票：如何实时找到异常成交量股票</li>
<li>如果 D-Wave 风险太大，可以考虑这三只量子 ETF 进行多元化投资</li>
<li>如何选择顶级评级股票</li>
<li>NVIDIA 的 13F 揭示了两个第三季度赢家——以及一个痛苦的失误</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Cardiol Therapeutics 吗？</h2>
<p>在考虑 Cardiol Therapeutics 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 Cardiol Therapeutics 并不在名单上。</p>
<p>虽然 Cardiol Therapeutics 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

CRDL

<p>Cardiol Therapeutics（多伦多证券交易所代码：CRDL）在周一的午盘交易中股价下跌了 17.2%，最低交易价格为 1.24 加元。该股票的交易量显著增加，共有 480,129 股易手。该公司的市值为 1.29 亿加元，报告的季度每股亏损为 0.12 加元。Cardiol Therapeutics 专注于开发针对心脏病的抗炎和抗纤维化疗法。尽管分析师给予其 “持有” 评级，但一些人认为在其他地方有更好的投资机会</p>

<p>Cardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) shares were down 17.2% during mid-day trading on Monday . The company traded as low as C$1.24 and last traded at C$1.25. Approximately 480,129 shares changed hands during mid-day trading, an increase of 342% from the average daily volume of 108,711 shares. The stock had previously closed at C$1.51.</p>
<div class="lb-trans"><p>Cardiol Therapeutics Inc.（多伦多证券交易所代码：CRDL - 获取免费报告）在周一的午盘交易中股价下跌了 17.2%。该公司的股价最低曾达到 C$1.24，最后交易价为 C$1.25。午盘交易中大约有 480,129 股成交，较平均每日成交量 108,711 股增加了 342%。该股票此前收盘价为 C$1.51。</p>
</div><p>Get <strong>Cardiol Therapeutics</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Cardiol Therapeutics</strong> 的提醒：</p>
</div><h2>Cardiol Therapeutics Price Performance</h2>
<div class="lb-trans"><h2>Cardiol Therapeutics 价格表现</h2>
</div><p>The company has a market capitalization of C$129.00 million, a P/E ratio of -3.15 and a beta of 1.31. The company has a debt-to-equity ratio of 1.59, a current ratio of 2.49 and a quick ratio of 6.84. The firm's 50-day moving average is C$1.50 and its 200-day moving average is C$1.65.</p>
<div class="lb-trans"><p>该公司的市值为 1.29 亿加元，市盈率为-3.15，贝塔值为 1.31。公司的债务与股本比率为 1.59，流动比率为 2.49，速动比率为 6.84。该公司的 50 日移动平均线为 C$1.50，200 日移动平均线为 C$1.65。</p>
</div><p>Cardiol Therapeutics (TSE:CRDL - Get Free Report) last issued its quarterly earnings data on Thursday, November 13th. The company reported C($0.12) earnings per share (EPS) for the quarter. Analysts predict that Cardiol Therapeutics Inc. will post -0.49 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Cardiol Therapeutics（多伦多证券交易所代码：CRDL - 获取免费报告）最近在 11 月 13 日（星期四）发布了季度财报。该公司报告本季度每股收益（EPS）为 C($0.12)。分析师预测 Cardiol Therapeutics Inc.在当前财政年度将发布-0.49 的每股收益。</p>
</div><h2>About Cardiol Therapeutics</h2>
<div class="lb-trans"><h2>关于 Cardiol Therapeutics</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Cardiol Therapeutics Inc NASDAQ: CRDLTSX: CRDL is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease.</p>
<div class="lb-trans"><p>Cardiol Therapeutics Inc.（纳斯达克代码：CRDL，TSX 代码：CRDL）是一家临床阶段的生命科学公司，专注于心脏病的抗炎和抗纤维化疗法的研究与临床开发。该公司的主要药物候选者 CardiolRxTM（大麻二酚）口服溶液，经过药品制造，并正在进行临床开发，用于治疗心脏病。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Cardiol Therapeutics</li>
<li>How to Invest in Small Cap Stocks</li>
<li>Go on a Shopping Spree With 3 Top Retail ETFs</li>
<li>Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time</li>
<li>If D-Wave Is Too Risky, Consider These 3 Quantum ETFs for Diversification</li>
<li>How to Choose Top Rated Stocks</li>
<li>NVIDIA’s 13F Reveals 2 Q3 Winners—And 1 Painful Miss</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Cardiol Therapeutics 更好</li>
<li>如何投资小盘股</li>
<li>与三只顶级零售 ETF 一起购物</li>
<li>异常成交量的股票：如何实时找到异常成交量股票</li>
<li>如果 D-Wave 风险太大，可以考虑这三只量子 ETF 进行多元化投资</li>
<li>如何选择顶级评级股票</li>
<li>NVIDIA 的 13F 揭示了两个第三季度赢家——以及一个痛苦的失误</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cardiol Therapeutics Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Cardiol Therapeutics 吗？</h2>
</div><p>Before you consider Cardiol Therapeutics, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Cardiol Therapeutics 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardiol Therapeutics wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 Cardiol Therapeutics 并不在名单上。</p>
</div><p>While Cardiol Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Cardiol Therapeutics 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Cardiol Therapeutics (TSE:CRDL) 股价下跌 17.2% - 以下是发生的情况